Nephrotic range proteinuria and acute heart failure

  • Matteo Landolfo
  • Giulia FioriniEmail author
  • Claudio Borghi

Case presentation

Dr. Landolfo and Dr. Fiorini

A 66-year-old woman with mild obesity, systemic hypertension and no history of previous treatment presented to our emergency department (ED) because of progressive exertional dyspnea and bilateral lower limbs swelling. At admission in the ED, arterial pressure was 188/86 mmHg, heart rate was 84 bpm and oxygen blood saturation was 96%. Physical examination confirmed bilateral symmetrical lower limbs pitting edema and bilateral rales at thoracic auscultation. Both laboratory and imaging findings were suggestive of acute decompensated heart failure (HF): BNP was 421 pg/mL and chest X-rays showed signs of congestion, mild pleural effusion and an enlarged cardiac shadow. Cardiac ultrasound revealed left ventricular concentric hypertrophy, mild left atrial enlargement and mild–moderate diastolic dysfunction (LVEF 60%, E/A 0.81, E/Eʹ 17, PAPS 30–40 mmHg). The patient was, thus, treated with intra-venous Furosemide and admitted to our Internal...


Compliance with ethical standards

Conflict of interest

The authors declare that they have no conflict of interest.

Statement of human and animal rights

All procedures performed were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.

Informed consent

Informed consent was obtained from the patient included in the study.


  1. 1.
    Gatta A, Verardo A, Bolognesi M (2012) Hypoalbuminemia. Intern Emerg Med 7(Suppl 3):S193–S199CrossRefGoogle Scholar
  2. 2.
    Bonilla-Palomas JL, Gamez-Lopez AL, Moreno-Conde M et al (2014) Hypoalbuminemia in acute heart failure patients: causes and its impact on hospital and long-term mortality. J Cardiac Fail 20:350–358CrossRefGoogle Scholar
  3. 3.
    Ancion A, Allepaerts S, Oury C et al (2017) Serum albumin level and hospital mortality in acute non-ischemic heart failure. ESC Heart Fail 4:138–145CrossRefGoogle Scholar
  4. 4.
    Liu M, Chan CP, Yan BP et al (2012) Albumin levels predict survival in patients with heart failure and preserved ejection fraction. Eur J Heart Fail 14:39–44CrossRefGoogle Scholar
  5. 5.
    Desai KV, Laine GA, Stewart RH et al (2008) Mechanics of the left ventricular myocardial interstitium: effects of acute and chronic myocardial edema. Am J Physiol Heart Circ Physiol 294:H2428–H2434CrossRefGoogle Scholar
  6. 6.
    Svenningsen P, Friis UG, Versland JB et al (2013) Mechanisms of renal NaCl retention in proteinuric disease. Acta Physiol 207:536–545CrossRefGoogle Scholar
  7. 7.
    Nakayama H, Koyama S, Kuragaichi T et al (2016) Prognostic value of rising serum albumin during hospitalization in patients with acute heart failure. Am J Cardiol 117:1305–1309CrossRefGoogle Scholar
  8. 8.
    Finfer S, Bellomo R, McEvoy S et al (2006) Effect of baseline serum albumin concentration on outcome of resuscitation with albumin or saline in patients in intensive care units: analysis of data from the saline versus albumin fluid evaluation (SAFE) study. BMJ 333:1044CrossRefGoogle Scholar
  9. 9.
    Vincent JL, Dubois MJ, Navickis RJ et al (2003) Hypoalbuminemia in acute illness: is there a rationale for intervention? A metanalysis of cohort studies and controlled trials. Ann Surg 237:319–334Google Scholar
  10. 10.
    Martin GS, Moss M, Wheeler AP et al (2005) A randomized, controlled trial of furosemide with or without albumin in hypoproteinemia patients with acute lung injury. Crit Care Med 33:1681–1687CrossRefGoogle Scholar
  11. 11.
    Heart Outcomes Prevention Evaluation (HOPE) Study Investigators (2000) Effects of ramipril on cardiovascular and microvascular outcomes in people with diabetes mellitus: results of the HOPE study and MICRO-HOPE substudy. Lancet 355(9200):253–259CrossRefGoogle Scholar
  12. 12.
    Zinman B, Wanner C, Lachin JM et al (2015) Empagliflozin, cardiovascular outcomes, and mortality in type 2 diabetes. N Engl J Med 373:2117–2128CrossRefGoogle Scholar
  13. 13.
    Cherney DIZ, Zinman B, Inzucchi SE et al (2017) Effects of empagliflozin on the urinary albumin-to-creatinine ratio in patients with type 2 diabetes and established cardiovascular disease: an exploratory analysis from the EMPA-REG OUTCOME randomised, placebo-controlled trial. Lancet Diabetes Endocrinol. Google Scholar
  14. 14.
    Wiviott SD, Raz I, Bonaca MP, DECLARE–TIMI 58 Investigators et al (2018) Dapagliflozin and cardiovascular outcomes in type 2 diabetes. N Engl J Med. Google Scholar
  15. 15.
    Ponikowski P, Voors AA, Anker SD et al (2016) 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure. The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC). Eur Heart J 37:2129–2200CrossRefGoogle Scholar

Copyright information

© Società Italiana di Medicina Interna (SIMI) 2019

Authors and Affiliations

  1. 1.Department of Surgical and Medical SciencesUniversity of BolognaBolognaItaly

Personalised recommendations